Earnings Feed
Start Free
Home/Insiders/Link Matthew
LM
SEC Insider//CIK 0001565950

Link Matthew

CIK 00015659503 companiesHOUSTON,, TX
SEC Profile

Transactions

50

Companies

3

Filings

14

CIK

0001565950

Recent Transactions

50 trades
  • Award
    FibroBiologics, Inc.$FBLG

    Stock Option (Right to Buy)

    2026-06-23+30,803→ 30,803 total
  • Sale
    Sight Sciences, Inc.$SGHT

    Common Stock

    2025-07-02$4.10/sh−4,889→ 832,293 total
  • Award
    FibroBiologics, Inc.$FBLG

    Stock Option (Right to Buy)

    2025-06-12+22,000→ 22,000 total
  • Award
    Sight Sciences, Inc.$SGHT

    Common Stock

    2025-05-16$3.02/sh+6,631→ 837,182 total
  • Sale
    Sight Sciences, Inc.$SGHT

    Common Stock

    2025-04-02$2.31/sh−5,042→ 830,551 total
  • Award
    Sight Sciences, Inc.$SGHT

    Common Stock

    2025-03-11+172,043→ 835,593 total
  • Sale
    Sight Sciences, Inc.$SGHT

    Common Stock

    2024-10-21$5.61/sh−21,831→ 663,550 total
  • Sale
    Sight Sciences, Inc.$SGHT

    Common Stock

    2024-10-18$5.98/sh−20,487→ 685,381 total
  • Sale
    Sight Sciences, Inc.$SGHT

    Common Stock

    2024-10-17$5.84/sh−20,970→ 705,868 total
  • Sale
    Sight Sciences, Inc.$SGHT

    Common Stock

    2024-10-16$5.91/sh−20,734→ 726,838 total
  • Award
    FibroBiologics, Inc.$FBLG

    Stock Option (Right to Buy)

    2024-08-27+5,000→ 5,000 total
  • Award
    Sight Sciences, Inc.$SGHT

    Common Stock

    2023-11-14+747,572→ 747,572 total
  • Award
    Sight Sciences, Inc.$SGHT

    Stock Option (Right to Buy)

    2023-11-14+526,430→ 526,430 total
  • Sale
    NUVASIVE INC

    Common Stock

    2020-06-08$67.00/sh−3,000→ 82,595 total
  • Award
    NUVASIVE INC

    RSUs

    2020-03-02+12,190→ 12,190 total
  • Exercise/Conversion
    NUVASIVE INC

    Common Stock

    2020-03-01+7,929→ 88,010 total
  • Exercise/Conversion
    NUVASIVE INC

    PRSUs

    2020-03-01−7,929→ 0 total
  • Tax Payment
    NUVASIVE INC

    Common Stock

    2020-03-01$65.81/sh−2,769→ 85,241 total
  • Sale
    NUVASIVE INC

    Common Stock

    2020-01-16$79.80/sh−3,000→ 80,081 total
  • Tax Payment
    NUVASIVE INC

    Common Stock

    2019-12-24$77.70/sh−8,672→ 83,081 total
  • Exercise/Conversion
    NUVASIVE INC

    Common Stock

    2019-12-24$26.62/sh+260→ 91,708 total
  • Exercise/Conversion
    NUVASIVE INC

    Common Stock

    2019-12-24$44.24/sh+12,500→ 91,448 total
  • Sale
    NUVASIVE INC

    Common Stock

    2019-12-24$77.38/sh−3,500→ 78,948 total
  • Exercise/Conversion
    NUVASIVE INC

    Employee Stock Option (Right to Buy)

    2019-12-24−260→ 0 total
  • Exercise/Conversion
    NUVASIVE INC

    Employee Stock Option (Right to Buy)

    2019-12-24−12,500→ 0 total
  • Gift
    NUVASIVE INC

    Common Stock

    2019-11-20−695→ 82,448 total
  • Sale
    NUVASIVE INC

    Common Stock

    2019-05-02$62.00/sh−10,100→ 83,143 total
  • Exercise/Conversion
    NUVASIVE INC

    Common Stock

    2019-03-01+19,157→ 100,074 total
  • Award
    NUVASIVE INC

    RSUs

    2019-03-01+12,825→ 12,825 total
  • Exercise/Conversion
    NUVASIVE INC

    PRSUs

    2019-03-01−14,403→ 0 total
  • Exercise/Conversion
    NUVASIVE INC

    PRSUs

    2019-03-01−4,754→ 0 total
  • Tax Payment
    NUVASIVE INC

    Common Stock

    2019-03-01$58.48/sh−7,267→ 92,807 total
  • Award
    NUVASIVE INC

    PRSUs

    2019-02-06+11,277→ 11,277 total
  • Award
    NUVASIVE INC

    PRSUs

    2019-02-06+4,754→ 4,754 total
  • Exercise/Conversion
    NUVASIVE INC

    Common Stock

    2019-02-01+2,660→ 81,949 total
  • Exercise/Conversion
    NUVASIVE INC

    PRSUs

    2019-02-01−2,660→ 0 total
  • Tax Payment
    NUVASIVE INC

    Common Stock

    2019-02-01$49.13/sh−1,032→ 80,917 total
  • Exercise/Conversion
    NUVASIVE INC

    Employee Stock Option (Right to Buy)

    2018-12-17−500→ 0 total
  • Exercise/Conversion
    NUVASIVE INC

    Common Stock

    2018-12-17$34.82/sh+500→ 79,616 total
  • Tax Payment
    NUVASIVE INC

    Common Stock

    2018-12-17$53.15/sh−327→ 79,289 total
  • Award
    NUVASIVE INC

    RSUs

    2018-12-03+20,065→ 20,065 total
  • Sale
    NUVASIVE INC

    Common Stock

    2018-11-21$62.22/sh−4,889→ 79,116 total
  • Sale
    NUVASIVE INC

    Common Stock

    2018-11-19$62.02/sh−1,382→ 84,005 total
  • Sale
    NUVASIVE INC

    Common Stock

    2018-11-16$62.01/sh−1,200→ 85,387 total
  • Award
    NUVASIVE INC

    PRSUs

    2018-02-07+7,929→ 7,929 total
  • Exercise/Conversion
    NUVASIVE INC

    PRSUs

    2018-02-01−2,660→ 2,660 total
  • Exercise/Conversion
    NUVASIVE INC

    Common Stock

    2018-02-01+2,660→ 87,170 total
  • Tax Payment
    NUVASIVE INC

    Common Stock

    2018-02-01$48.50/sh−1,027→ 86,143 total
  • Exercise/Conversion
    NUVASIVE INC

    Employee Stock Option (Right to Buy)

    2017-12-27−5,350→ 0 total
  • Exercise/Conversion
    NUVASIVE INC

    Employee Stock Option (Right to Buy)

    2017-12-27−2,150→ 0 total

Companies

3

Recent Filings

14

Address

C/O FIBROBIOLOGICS, INC. 9350 KIRBY DRIVE., SUITE 300

HOUSTON,, TX, 77054

View on SEC.gov